GL1X · GenesisL1 explorer

MolNFT v1 · #47360 · protein

Crystal structure analysis of the MMP13 catalytic domain in complex with specific inhibitor

2OW9 · Collagenase 3: “Crystal structure analysis of the MMP13 catalytic domain in complex with specific inhibitor”. X-ray diffraction, 5 ligands (SP6, HAE, CA), 2 pockets (best druggability 0.73). MolNFT v1 #47360 on GenesisL1: 3D…

PDB
2OW9
Type
protein
Length
333 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Collagenase 3
EC
3.4.24.-
UniProt
P45452
Ligands
SP6, HAE, CA, ZN, SO4
Pockets
2 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 24% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACollagenase 3 (EC 3.4.24.-)protein16724% helix, 19% strandP45452
BCollagenase 3 (EC 3.4.24.-)protein16623% helix, 19% strandP45452

Ligands and binding sites

  • SP6 · Benzyl 6-benzyl-5,7-dioxo-6,7-dihydro-5H-[1,3]thiazolo[3,2-c]pyrimidine-2-carboxylate · ligand · 2 copies · chains A, B
  • HAE · Acetohydroxamic acid · ligand · 2 copies · chains A, B
  • CA · Calcium ion · metal · 7 copies · chains A, B
  • ZN · Zinc ion · metal · 4 copies · chains A, B
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17190.730.7975ZN, SP6, HAE
22520.630.8143SP6, HAE

Interfaces

1 interface between chains.

  • A–B · 1224 Ų buried · 15 hydrogen bonds · protein-protein

Compared structures

  • 2OW9 · Crystal structure analysis of the MMP13 catalytic domain in complex with specific… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.